Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 167

Similar articles for PubMed (Select 23407543)

1.

Use of high-dose ganciclovir for the treatment of cytomegalovirus replication in solid organ transplant patients with ganciclovir resistance-inducing mutations.

Gracia-Ahufinger I, Gutiérrez-Aroca J, Cordero E, Vidal E, Cantisán S, del Castillo D, Martín-Gandul C, Rivero A, Torre-Cisneros J.

Transplantation. 2013 Apr 27;95(8):1015-20. doi: 10.1097/TP.0b013e31828555ac.

PMID:
23407543
2.

Cytomegalovirus in immunocompromised children.

Vora SB, Englund JA.

Curr Opin Infect Dis. 2015 Aug;28(4):323-9. doi: 10.1097/QCO.0000000000000174.

PMID:
26098503
3.

Valganciclovir for Congenital Cytomegalovirus.

Korndewal MJ, de Vries JJ, de Melker HE.

N Engl J Med. 2015 Jun 18;372(25):2462-3. doi: 10.1056/NEJMc1504937#SA3. No abstract available.

PMID:
26083218
4.

Valganciclovir for Congenital Cytomegalovirus.

Schornagel FA, Oudesluys-Murphy AM, Vossen AC.

N Engl J Med. 2015 Jun 18;372(25):2462. doi: 10.1056/NEJMc1504937#SA2. No abstract available.

PMID:
26083217
5.

Valganciclovir for Congenital Cytomegalovirus.

Natale F, De Curtis M.

N Engl J Med. 2015 Jun 18;372(25):2462. doi: 10.1056/NEJMc1504937#SA1. No abstract available.

PMID:
26083216
6.

Valganciclovir for Congenital Cytomegalovirus.

Kimberlin DW, Aban I, Acosta EP.

N Engl J Med. 2015 Jun 18;372(25):2463. doi: 10.1056/NEJMc1504937. No abstract available.

7.

Evaluation of ganciclovir resistance in cytomegalovirus infection of renal transplant recipients in tehran.

Javad Hosseini SM, Nemati E, Behzadian F, Einollahi B, Rahimi Petrudy A, Sohraby M, Taghipour M, Motalebi M.

Transplant Proc. 2015 May;47(4):1140-2. doi: 10.1016/j.transproceed.2014.10.066.

PMID:
26036539
8.

Leflunomide: a treatment option for ganciclovir-resistant cytomegalovirus infection after renal transplantation.

Andrassy J, Illner WD, Rentsch M, Jaeger G, Jauch KW, Fischereder M.

NDT Plus. 2009 Apr;2(2):149-51. doi: 10.1093/ndtplus/sfp004.

9.

Lower dose valganciclovir for the prevention of cytomegalovirus after solid organ transplantation: an important tradeoff.

Arasaratnam RJ.

Transpl Infect Dis. 2015 Apr 28. doi: 10.1111/tid.12397. [Epub ahead of print] No abstract available.

PMID:
25919304
10.

Response to: lower dose valganciclovir for prevention of cytomegalovirus after solid organ transplant: an important tradeoff.

Stevens DR, Sawinski D, Blumberg E, Bloom RD, Trofe-Clark J.

Transpl Infect Dis. 2015 Apr 28. doi: 10.1111/tid.12396. [Epub ahead of print] No abstract available.

PMID:
25919221
11.

Cytomegalovirus appendicitis in solid organ transplant patients, two cases and a review.

McCarty TP, Lee RA, Herfel BM, Pappas PG.

J Clin Virol. 2015 May;66:48-50. doi: 10.1016/j.jcv.2015.03.004. Epub 2015 Mar 7.

PMID:
25866336
12.
13.

Valganciclovir inhibits human adenovirus replication and pathology in permissive immunosuppressed female and male Syrian hamsters.

Toth K, Ying B, Tollefson AE, Spencer JF, Balakrishnan L, Sagartz JE, Buller RM, Wold WS.

Viruses. 2015 Mar 23;7(3):1409-28. doi: 10.3390/v7031409.

14.

Adoptive T cell immunotherapy for treatment of ganciclovir-resistant cytomegalovirus disease in a renal transplant recipient.

Macesic N, Langsford D, Nicholls K, Hughes P, Gottlieb DJ, Clancy L, Blyth E, Micklethwaite K, Withers B, Majumdar S, Fleming S, Sasadeusz J.

Am J Transplant. 2015 Mar;15(3):827-32. doi: 10.1111/ajt.13023. Epub 2015 Feb 3.

PMID:
25648555
15.

Prophylactic acyclovir and preemptive ganciclovir to prevent cytomegalovirus disease in children after hematopoietic stem cell transplant.

Tavil B, Azik FM, Bozkaya I, Gokcebay DG, Tezer H, Tunc B, Uckan D.

Exp Clin Transplant. 2014 Oct;12(5):462-8.

PMID:
25299374
16.

Trip to immunity: resistant cytomegalovirus infection in a lung transplant recipient.

Kneidinger N, Giessen C, von Wulffen W, Milger K, Schramm R, Jäger G, Nitschko H, Striebinger H, Behr J, Neurohr C.

Int J Infect Dis. 2014 Nov;28:140-2. doi: 10.1016/j.ijid.2014.06.009. Epub 2014 Sep 26.

17.

Cytomegalovirus central nervous system compartmentalization in a patient presenting with AIDS.

Trentalange A, Calcagno A, Raviolo S, Prochet A, Audagnotto S, Ghisetti V, Di Perri G, Bonora S.

Antivir Ther. 2015;20(3):357-9. doi: 10.3851/IMP2849. Epub 2014 Aug 20.

PMID:
25138134
18.

Safety of alternative antiviral agents for neonatal herpes simplex virus encephalitis and disseminated infection.

Wang Y, Smith KP.

J Pediatr Pharmacol Ther. 2014 Apr;19(2):72-82. doi: 10.5863/1551-6776-19.2.72. Review.

19.

Resolution of Mild Ganciclovir-Resistant Cytomegalovirus Disease with Reduced-Dose Cidofovir and CMV-Hyperimmune Globulin.

Patel SJ, Kuten SA, Knight RJ, Hong DM, Gaber AO.

J Transplant. 2014;2014:342319. doi: 10.1155/2014/342319. Epub 2014 Jun 1.

20.

Increased osteoprotegerin predicts poor virological outcome during anticytomegalovirus therapy in solid organ transplant recipients.

Ueland T, Rollag H, Hartmann A, Jardine A, Humar A, Bignamini AA, Åsberg A, Aukrust P.

Transplantation. 2015 Jan;99(1):100-5. doi: 10.1097/TP.0000000000000227.

PMID:
24983306
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk